- UTHR -0.67%
Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term
Yahoo Finance · 4 days ago
Sirius XM
Search results
- 264.27Add to watchlist-1.78 (-0.67%)At close: Fri. May 10, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open266.00High269.81Low264.01
- Mkt Cap11.72BP/E (TTM)12.51Div & YieldN/A & N/A
- Prev. Close266.0552 Wk. Low204.4452 Wk. High269.81
What analysts are sayingTop storiesRelated stocks
5 days ago · UTHR is a biotechnology company that develops products for chronic and life-threatening diseases. See its stock price, financial performance, analyst forecast, news, and events.
- 11.20B
- 2.33B
- 984.80M
- 47.06M
People also ask
Should you buy United Therapeutics (UTHR) stock?
What does UTHR stand for?
Is UTHR a good stock to buy?
How much did Christopher Causey sell United Therapeutics Corp (UTHR)?
4 days ago · UTHR boasts a Momentum Style Score of A and VGM Score of A, and holds a Zacks Rank #2 (Buy) rating. Shares of United Therapeutics has seen some interesting price action recently; the stock is up ...
6 days ago · United Therapeutics (UTHR) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank. Studies have...
5 days ago · On May 3, 2024, Director Christopher Causey sold 2,240 shares of United Therapeutics Corp (NASDAQ:UTHR) as reported in a recent SEC Filing. The transaction occurred at a price of $259.91 per...
2 days ago · 4. $22.86. $22.86. $22.86. UTHR Earnings Date and Information. United Therapeutics last announced its earnings results on May 1st, 2024. The biotechnology company reported $6.17 earnings per share for the quarter, beating the consensus estimate of $5.63 by $0.54. The company earned $677.70 million during the quarter, compared to the consensus ...
- contact@marketbeat.com
- When is United Therapeutics's earnings date?United Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 28th, 20...
- Did United Therapeutics beat their earnings estimates last quarter?In the previous quarter, United Therapeutics (NASDAQ:UTHR) reported $5.38 earnings per share (EPS) to beat the analysts' consensus estimate of $5.1...
- How can I listen to United Therapeutics's earnings conference call?The conference call for United Therapeutics's latest earnings report can be listened to online. Listen to Conference Call
- How can I read United Therapeutics's conference call transcript?The conference call transcript for United Therapeutics's latest earnings report can be read online. Read Transcript
- How can I view United Therapeutics's earnings report?United Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing
- How much revenue does United Therapeutics generate each year?United Therapeutics (NASDAQ:UTHR) has a recorded annual revenue of $1.94 billion.
- How much profit does United Therapeutics generate each year?United Therapeutics (NASDAQ:UTHR) has a recorded net income of $727.30 million. UTHR has generated $18.15 earnings per share over the last four qua...
- What is United Therapeutics's price-to-earnings ratio?United Therapeutics (NASDAQ:UTHR) has a trailing price-to-earnings ratio of 12.64 and a forward price-to-earnings ratio of 11.80.
- What is United Therapeutics's EPS forecast for next year?United Therapeutics's earnings are expected to grow from $19.44 per share to $22.01 per share in the next year, which is a 13.22% increase.
4 days ago · United Therapeutics Corp. advanced stock charts by Barron's. View UTHR historical stock data and compare to other stocks, and exchanges.
6 days ago · A high-level overview of United Therapeutics Corporation (UTHR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
